Abstract

DNA-Damage Response (DDR) proteins are crucial for maintaining the integrity of the genome by identifying and repairing errors in DNA. Variants affecting their function can have severe consequences since failure to repair damaged DNA can result in cells turning cancerous. Here, we compare germline and somatic variants in DDR genes, specifically looking at their locations in the corresponding three-dimensional (3D) structures, Pfam domains, and protein–protein interaction interfaces. We show that somatic variants in metastatic cases are more likely to be found in Pfam domains and protein interaction interfaces than are pathogenic germline variants or variants of unknown significance (VUS). We also show that there are hotspots in the structures of ATM and BRCA2 proteins where pathogenic germline, and recurrent somatic variants from primary and metastatic tumours, cluster together in 3D. Moreover, in the ATM, BRCA1 and BRCA2 genes from prostate cancer patients, the distributions of germline benign, pathogenic, VUS, and recurrent somatic variants differ across Pfam domains. Together, these results provide a better characterisation of the most recurrent affected regions in DDRs and could help in the understanding of individual susceptibility to tumour development.

Highlights

  • DNA is subject to continuous damage-causing alterations in both somatic and germline tissues

  • We investigated the occurrence of DNA-Damage Response (DDR) germline and somatic variants according to the ClinVar and COSMIC databases, respectively, in Pfam domains and protein interaction interfaces

  • In this study we show that an integrative structural analysis of affected regions in the DDR protein-coding genes can help identify susceptibility to tumour development

Read more

Summary

Introduction

DNA is subject to continuous damage-causing alterations in both somatic and germline tissues. A list of 276 DDR genes was recently identified by The Cancer Genome Atlas (TCGA) DNA Damage Repair Analysis Working Group, which systematically analysed potential causes of loss of DDR function across 33 different cancer types and their consequences in human ­cancer[2]. This set of genes provides the basis for the mechanistic and therapeutic analysis of the role of DDR in cancer. Pan-cancer studies provide evidence for factors affecting predisposition to different cancer types, highlighting rare germline cancer susceptibility variants that affect tumour suppressor genes including ATM, BRCA1, BRCA2, BRIP1, and PALB24. We look at the variants in protein interaction interfaces

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call